Category:

Health

Latest

47 districts reported over 10 pc COVID-19 positivity rate for week ending July 15: Govt

PM Modi said the country stands at a point in its battle with the pandemic where apprehensions about a third wave are being continuously expressed. These states have accounted for 80 percent of new COVID-19 cases last week and 84 percent of deaths, he noted in his closing remarks, specifically mentioning the rise in infections in Kerala and Maharashtra as a matter of grave concern for the country.

read more

DCGI examining Zydus Cadila’s COVID vaccine for children, says Dr VK Paul

The Centre in an affidavit told the Delhi High Court that pharmaceutical major Zydus Cadila’s COVID-19 vaccine may be available in the near future for children in the age group of 12 to 18 years. Zydus Cadila has concluded its trial for children between the age group of 12 to 18 and is subject to statutory permissions, the Centre added.

read more

No negligence of normal vaccination programme for children due to COVID-19 disruptions: Govt  

.“These reports are not based on facts and do not reflect the true picture and the Ministry along with all States and UTs and development partners, have worked towards mitigating negative impacts of COVID-19 and taking urgent actions to ensure that children receive life-saving vaccines under UIP,” said the ministry on Friday.

read more

Alcohol linked to over 62,000 cancer cases in India last year: Lancet study

These cancers have well-established causal links to alcohol consumption, and the estimates of the direct associations with alcohol in the new study are the first of their kind for 2020.”Trends suggest that although there is a decrease in alcohol consumption per person in many European countries, alcohol use is on the rise in Asian countries such as China and India, and in sub-Saharan Africa,” said Harriet Rumgay of the International Agency for Research on Cancer (IARC), France.

read more

Pfizer agrees to pay $345 mln to resolve EpiPen pricing lawsuit

The litigation followed a public outcry in 2016 after Mylan, which owns the rights to market and distribute the devices, raised the price of a pair of EpiPens to $600, from $100 in 2008, putting it in the center of an ongoing U.S. debate over the high cost of medicines. The lawsuit accused Mylan and Pfizer, which manufactured the EpiPen for Mylan, of engaging in anticompetitive conduct that allowed them to maintain a monopoly over the market for the devices and their profitable revenues.

read more

Strong rise in political risk globally:Coface Political Risk Index

Inflationary risks have been in the news in recent months. In this context, the annual update of the Coface Political Risk Index shows a strong rise in political risk across the world, and particularly in the emerging countries. Indeed, figures show a deterioration in living standards and purchasing power, as well as a rise in inequalities observed following the COVID-19 crisis. At this stage, these conditions are not necessarily leading to popular uprisings, which remain limited by people’s capacity to mobilise.

read more

J&J recalls Aveeno, Neutrogena sunscreens after carcinogen found in sprays

After internal testing identified low levels of benzene in some samples, J&J said it has decided to recall these products from the market.

Benzene is classified as a human carcinogen, a substance that could potentially cause cancer depending on the level and extent of exposure.

“While benzene is not an  ingredient in  any of our  sunscreen products, it was detected in some samples of the impacted aerosol sunscreen finished products,” the company said.

read more

Policybazaar launches Employee Health Insurance

“The need for a food delivery company with 1000 delivery riders is very different from a small corporate that has tech geniuses working from home,” The one-size-fits-all approach cannot work anymore since businesses, their operations and their wallets are different and complex,” said Sarbvir Singh, CEO – Policybazaar.com. 

read more